272 related articles for article (PubMed ID: 28508095)
1. Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicity.
Bretagne M; Jouinot A; Durand JP; Huillard O; Boudou Rouquette P; Tlemsani C; Arrondeau J; Sarfati G; Goldwasser F; Alexandre J
Cancer Chemother Pharmacol; 2017 Jul; 80(1):45-53. PubMed ID: 28508095
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a non cystatin-C-based novel algorithm to calculate individual glomerular filtration rate in cancer patients receiving carboplatin.
Holweger K; Lipp HP; Beijnen JH; Bokemeyer C; Hartmann JT
Cancer Chemother Pharmacol; 2011 Sep; 68(3):693-701. PubMed ID: 21136060
[TBL] [Abstract][Full Text] [Related]
3. Analysis of carboplatin dosing in patients with a glomerular filtration rate greater than 125 mL/min: To cap or not to cap? A retrospective analysis and review.
Morrow A; Garland C; Yang F; De Luna M; Herrington JD
J Oncol Pharm Pract; 2019 Oct; 25(7):1651-1657. PubMed ID: 30336729
[TBL] [Abstract][Full Text] [Related]
4. Cystatin C-Creatinine Based Glomerular Filtration Rate Equation in Obese Chronic Kidney Disease Patients: Impact of Deindexation and Gender.
Lemoine S; Panaye M; Pelletier C; Bon C; Juillard L; Dubourg L; Guebre-Egziabher F
Am J Nephrol; 2016; 44(1):63-70. PubMed ID: 27400282
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of renal function in intensive care: plasma cystatin C vs. creatinine and derived glomerular filtration rate estimates.
Le Bricon T; Leblanc I; Benlakehal M; Gay-Bellile C; Erlich D; Boudaoud S
Clin Chem Lab Med; 2005; 43(9):953-7. PubMed ID: 16176176
[TBL] [Abstract][Full Text] [Related]
6. Prediction of carboplatin clearance calculated by patient characteristics or 24-hour creatinine clearance: a comparison of the performance of three formulae.
Okamoto H; Nagatomo A; Kunitoh H; Kunikane H; Watanabe K
Cancer Chemother Pharmacol; 1998; 42(4):307-12. PubMed ID: 9744776
[TBL] [Abstract][Full Text] [Related]
7. Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing.
Donahue A; McCune JS; Faucette S; Gillenwater HH; Kowalski RJ; Socinski MA; Lindley C
Cancer Chemother Pharmacol; 2001 May; 47(5):373-9. PubMed ID: 11391850
[TBL] [Abstract][Full Text] [Related]
8. Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma.
Shepherd ST; Gillen G; Morrison P; Forte C; Macpherson IR; White JD; Mark PB
Eur J Cancer; 2014 Mar; 50(5):944-52. PubMed ID: 24445148
[TBL] [Abstract][Full Text] [Related]
9. Simple cystatin C formula compared to sophisticated CKD-EPI formulas for estimation of glomerular filtration rate in the elderly.
Bevc S; Hojs R; Ekart R; Gorenjak M; Puklavec L
Ther Apher Dial; 2011 Jun; 15(3):261-8. PubMed ID: 21624073
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cystatin C and creatinine-based equations for GFR estimation after living kidney donation.
Issa N; Kukla A; Jackson S; Riad SM; Foster MC; Matas AJ; Eckfeldt JH; Ibrahim HN
Transplantation; 2014 Oct; 98(8):871-7. PubMed ID: 24825515
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies.
de Lemos ML; Hsieh T; Hamata L; Levin A; Swenerton K; Djurdjev O; Vu T; Hu F; Conklin J; Malfair Taylor SC
Gynecol Oncol; 2006 Dec; 103(3):1063-9. PubMed ID: 16875719
[TBL] [Abstract][Full Text] [Related]
12. Cystatin C, beta 2-microglobulin, and retinol-binding protein as indicators of glomerular filtration rate: comparison with plasma creatinine.
Donadio C; Lucchesi A; Ardini M; Giordani R
J Pharm Biomed Anal; 2001 Mar; 24(5-6):835-42. PubMed ID: 11248475
[TBL] [Abstract][Full Text] [Related]
13. Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer Institute.
Millward MJ; Webster LK; Toner GC; Bishop JF; Rischin D; Stokes KH; Johnston VK; Hicks R
Aust N Z J Med; 1996 Jun; 26(3):372-9. PubMed ID: 8811211
[TBL] [Abstract][Full Text] [Related]
14. Creatinine clearance, Cockcroft-Gault formula and cystatin C: estimators of true glomerular filtration rate in the elderly?
Burkhardt H; Bojarsky G; Gretz N; Gladisch R
Gerontology; 2002; 48(3):140-6. PubMed ID: 11961366
[TBL] [Abstract][Full Text] [Related]
15. A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients.
Schmitt A; Gladieff L; Lansiaux A; Bobin-Dubigeon C; Etienne-Grimaldi MC; Boisdron-Celle M; Serre-Debauvais F; Pinguet F; Floquet A; Billaud E; Le Guellec C; Penel N; Campone M; Largillier R; Capitain O; Fabbro M; Houede N; Medioni J; Bougnoux P; Lochon I; Chatelut E
Clin Cancer Res; 2009 May; 15(10):3633-9. PubMed ID: 19401344
[TBL] [Abstract][Full Text] [Related]
16. Correlation of Serum Cystatin C with Glomerular Filtration Rate in Patients Receiving Platinum-Based Chemotherapy.
Cavalcanti E; Barchiesi V; Cerasuolo D; Di Paola F; Cantile M; Cecere SC; Pignata S; Morabito A; Costanzo R; Di Maio M; Perrone F
Anal Cell Pathol (Amst); 2016; 2016():4918325. PubMed ID: 28078200
[No Abstract] [Full Text] [Related]
17. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients.
Mussap M; Dalla Vestra M; Fioretto P; Saller A; Varagnolo M; Nosadini R; Plebani M
Kidney Int; 2002 Apr; 61(4):1453-61. PubMed ID: 11918752
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of carboplatin AUC dosing in patients with a BMI>or=27 or cachexia.
Herrington JD; Tran HT; Riggs MW
Cancer Chemother Pharmacol; 2006 Jan; 57(2):241-7. PubMed ID: 16133538
[TBL] [Abstract][Full Text] [Related]
19. Extension of the Calvert formula to patients with severe renal insufficiency.
Oguri T; Shimokata T; Ito I; Yasuda Y; Sassa N; Nishiyama M; Hamada A; Hasegawa Y; Ando Y
Cancer Chemother Pharmacol; 2015 Jul; 76(1):53-9. PubMed ID: 25957958
[TBL] [Abstract][Full Text] [Related]
20. Carboplatin Dosing Accuracy by Estimation of Glomerular Filtration versus Creatinuria in Cancer Patients.
Graciano Vera N; Pino Villarreal L; Ureña Vargas J
Chemotherapy; 2018; 63(3):137-142. PubMed ID: 29768260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]